June 05, 2020

[STOCK WATCH] PRP decreases 4%

PUBLISHED : October 25, 2016 - 12:01

UPDATED : October 25, 2016 - 17:40

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • 트위터
  • sms

- The Return On Risk, -10.3, is in the lower class, it is lower than the industrial mean
- All related stocks also decline. Distribution industry -1.53%
- Institutions and Individuals buy, Foreigners sell
- Turnover Rate and Price Range both proper
- The main shareholding group is Individuals

Market Review

On Oct. 25, Pharma Research Products (214450) declined 4.39% to 41,350 won (US$ 36.30). It had declined 19.71% through the past month. Standard deviation, the volatility index for stock price, was 1.9% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of Pharma Research Products was not so high, the earnings rate for 1 month was also the lowest with decline of stock price. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -10.3%. As bearish stock price trend, the return-on-risk was poor, compared with its peer group. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -9.1, and thus it is hard to say that the industrial comparison performance was positive. 

Close CompetitorsEarning rate (%)STD (1Mo)Return on
Risk (1Mo)
1 Mo3 Mo6 Mo
CJ FW(051500)-12.0%-15.8%-32.9%2.1%-5.6
DAOU DATA(032190)-11.5%-20.6%-20.9%2.0%-5.7
Seobu T&D(006730)1.3%-7.5%-17.0%1.6%0.8

Earnings & Valuation
PRP(214450): 2Q(Apr ~ June) of 2016 Earnings (reported at Aug. 17. 2016)
 RevenueOperating IncomeNet Income
2Q of 2016120.4 T41.4 T46.6 T
Previous Quarter1.9% increase13.7% increase12.6% increase
YoY43.0% increase6.4% increase53.8% increase

Investor Group
Institutions and Individuals buy, Foreigners sell
Institutions have been buying for the past 3 trading days and foreigners have been buying for the past 2 trading days. As a shareholding sum by investor group for the past 4 weeks, institutions have bought 7,103 shares with trending trade and individuals have bought 2,890 shares lessening its position. However, during the same period, foreigners have sold 9,993 shares.

Cumulated shareholdings per investor group (1Mo) Total shareholdings per investor group
* Other Investor groups, included as "other corporations", are considered as "Individuals".

By HeRo (

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.

  • 페이스북
  • 트위터
  • sms
Herald Corporation|CEO : Kwon Chung Won
Publisher. Editor : Kwon Chung Won
Chief Privacy Officer & Juvenile Protection Manager : Yang Sung-jin
Title : The Investor|Date of registration : 2015.04.28
Company Registration No. 104-81-06004
Mail-Order Business Registration 2016 - Seoul Yongsan - 00590
Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea
T : +82-2-727-0114|Business info
Gov’t registration No. Seoul 아04099